In an exclusive conversation with Rahul Kanwal, Executive Director of Business Today, Adar Poonawalla, CEO of the Serum Institute of India, shares his insights on the sidelines of the World Economic Forum 2025 in Davos. As the driving force behind the world’s largest vaccine manufacturer, Poonawalla discusses the Serum Institute’s pivotal role in shaping global healthcare. Key topics include the ongoing innovations in vaccine development, challenges in global health equity, and strategies to ensure preparedness for future pandemics. Poonawalla highlights the Serum Institute’s efforts to leverage cutting-edge technologies like AI to enhance vaccine production and distribution while ensuring affordability and accessibility. Additionally, he provides insights into the Serum Institute’s collaborations with governments and international organizations to address pressing health challenges and the company’s future roadmap for tackling emerging diseases.